this post was submitted on 25 Aug 2024
232 points (99.6% liked)

Health - Resources and discussion for everything health-related

2291 readers
58 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 1 year ago
MODERATORS
 

A team of researchers in Kansai is set to begin clinical trials next month to develop medicine to help grow teeth.

The researchers, including from Kitano Hospital and Kyoto University Hospital, will conduct trials for teething medicine, aimed at treating people with congenital anodontia who are born with few teeth.

To check its safety, the experimental drug will first be administered to adult men who have lost back teeth, before it is tested on children with congenital anodontia. The team aims to put the treatment into practical use in around 2030.

you are viewing a single comment's thread
view the rest of the comments
[–] Hobthrob@lemmy.world 26 points 2 months ago (2 children)

The article says that they hope to regrow teeth for people who have lost their teeth to cavities, and the initial test is being done on adults who have lost back teeth. So pretty much the exact target audience you say it wouldn't target.

[–] AwesomeLowlander@sh.itjust.works 2 points 2 months ago (2 children)

It's really weird though. Why specify that you're targeting specifically kids with a disorder when your treatment is being tested on adults, and would work on any adult who has lost teeth for any reason?

[–] ColeSloth@discuss.tchncs.de 1 points 2 months ago (1 children)

Because /hobthrob is incorrect. This medication will not and cannot be used to regrow teeth in people that don't have the genetic disorder "congenital anodontia". The drug can only help that >1% with the disorder.

[–] AwesomeLowlander@sh.itjust.works 1 points 2 months ago* (last edited 2 months ago)

That's not what the article says though

[–] AliasAKA@lemmy.world 1 points 2 months ago (1 children)

Speculating, but probably because kids without any teeth and a genetic basis of that disease would pay for this treatment out of medical coverage, not dental coverage, at least in the US, and getting it approved for specifically that indication is easier, faster, and likely higher profit than the admittedly larger population but smaller insured availability of funds that would be the dental market.

Markets shouldn’t drive drug research, public health benefit should, but shrugs

[–] AwesomeLowlander@sh.itjust.works 2 points 2 months ago (1 children)

Good thought, but it looks like they're a Japanese team conducting trials in Japan, so the US excuse for an insurance system shouldn't be a factor? IDK

[–] AliasAKA@lemmy.world 2 points 2 months ago

Quick search tells me that they have a national dental plan that covers 70%, but has limits on which procedures materials etc are covered. In other words, they may not cover this procedure if it’s more expensive than a traditional implant.

Additionally, there’s harmonization efforts between Japan and the US FDA; if fully expect they’re running clinical trials in JP with hopes for a later release abroad, and the US is a huge market so they’d still be angling that I’d think.

[–] ColeSloth@discuss.tchncs.de 0 points 2 months ago* (last edited 2 months ago) (1 children)

My bad. I guess this is a completely different thing from one I read about around 6 months ago, then.

*Nevermind. This is the same thing and everyone else in here is mistaken. Go read any other articles about this. The medication suppresses a protein that people with congenital anodontia have, and that is what makes them start growing teeth. Normal people do not have that protein issue, so the drug can't help.

[–] AwesomeLowlander@sh.itjust.works 3 points 2 months ago (2 children)

Given the average quality of science reporting and the lack of actual journal articles, it might be the same thing with a misunderstanding in either the earlier article or this one.

[–] orrk@lemmy.world 2 points 2 months ago (1 children)

science reporting is awesome, I love when people start pushing random BS because they decided they needed to "dumb it down" because they themselves were too dumb to get it in the first place

[–] ColeSloth@discuss.tchncs.de 1 points 2 months ago

Well that's what happened with this article. Their little mention of growing teeth lost from cavities is complete hyperbole. This treatment suppresses a protein found in the less than 1% of people who have congenital anodontia. It can't be used at all to help grow teeth for anyone else.

[–] ColeSloth@discuss.tchncs.de 0 points 2 months ago (1 children)

Oh man. It seems the only misunderstanding is that no one else in here understands the article or what congenital anodontia actually is. So what I had initially stated, and per this article, it won't help 99% of people.

[–] AwesomeLowlander@sh.itjust.works 1 points 2 months ago (1 children)

The treatment may be applied in the future to people who have permanently lost teeth due to cavities and other problems.

How do we not understand the article? If the article is full of bull, that's another story

[–] ColeSloth@discuss.tchncs.de 1 points 2 months ago

The context and explanation of everything else in the article in everything but that one cavity paragraph explains what it can treat and how it does it. Then that one paragraph says it may be used. In full context of the entire article (which is trash) it can be interpreted as not really for cavity missing teeth.